CDC Website CDC Website

To Join the NPIN community or

Home » Addressing Health Disparities in NIDDK Diseases (R01)

Addressing Health Disparities in NIDDK Diseases (R01)

This Funding Opportunity Announcement (FOA) invites research projects to improve understanding of the causes of high priority diseases in the United States and reducing/eliminating health disparities. Research is encouraged in the following high priority diseases within the scientific mission areas of the NIDDK: diabetes; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; sickle cell disease, specifically, studies in complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; hematologic diseases, including studies in abnormal hemoglobin synthesis; metabolic diseases; gastrointestinal, hepatic, and renal complications from infection with HIV. Clinical trials are not permitted in response to this FOA.

Funding Organization
Locations
National
Fund Location Notes
Eligible Organizations
Number of Awards Given
Varies

Minimum Amount: 

$0.00

Maximum Amount: 

$0.00

Average Amount: 

$0.00

Award Amount: 

$0.00
Award Amount Notes
Notes
Reissue of PA-13-183
Letter of Intent Date
10/19/16
Application Due Date
1/7/17
Award Date
10/19/16
Open Ended Date
10/19/16
Project Start Date
10/19/16
Application Contact
Lawrence
Agodoa, M.D.
United States
(301) 594-1932
agodoal@mail.nih.gov
(301) 594-1932
Technical Contact
GrantsInfo
GrantsInfo@nih.gov
United States
(301) 710-0267
(301) 710-0267
Fund Duration
The maximum project period is 5 years.
Subjects
Audiences
Application Process
It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.
Focus Area

Fund Number: 

PA-17-021

Fund ID: 

5216

Last Updated: 

10/19/16